logo
Select company
Select metric
87.02%Cash to Assets Ratio
VS
Market
98
Sector
91
Industry
86
History
90
$ 12.18Close
$ 5.92 - $ 13.6 52-Week Range
Ticker Information

Ticker

OCUL

Company Name

OCULAR THERAPEUTIX INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

OCULAR THERAPEUTIX INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

OCUL - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 451.33M$ 392.75M87.02%
3/31/2025$ 405.92M$ 351.3M86.54%
12/31/2024$ 457.94M$ 393.72M85.98%
9/30/2024$ 490.37M$ 428.83M87.45%
6/30/2024$ 517.09M$ 461.3M89.21%
3/31/2024$ 538.95M$ 484.65M89.93%
12/31/2023$ 252.06M$ 197.57M78.38%
9/30/2023$ 162.38M$ 112.31M69.17%
6/30/2023$ 122.56M$ 68.37M55.79%
3/31/2023$ 128.57M$ 80.79M62.84%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • OCULAR THERAPEUTIX INC's latest trailing twelve months (TTM) Cash to Assets stands at 73.72%.
  • Over the past 5 years, OCULAR THERAPEUTIX INC's average Cash to Assets has been 79.65%.
  • The median Cash to Assets for OCULAR THERAPEUTIX INC during this period was 82.07%
  • OCULAR THERAPEUTIX INC reached its highest Cash to Assets over the past 5 years at 89.93%.
  • The lowest Cash to Assets recorded by OCULAR THERAPEUTIX INC in the same timeframe 55.79%

OCULAR THERAPEUTIX INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
IBRX : IMMUNITYBIO INC 34.24%BEAM : BEAM THERAPEUTICS INC 20.76%RXRX : RECURSION PHARMACEUTICALS INC 40.56%AGIO : AGIOS PHARMACEUTICALS INC 5.5%NTLA : INTELLIA THERAPEUTICS INC 17.37%KYMR : KYMERA THERAPEUTICS INC 30.2%LQDA : LIQUIDIA CORP 68.73%EYPT : EYEPOINT PHARMACEUTICALS INC 23.67%ZVRA : ZEVRA THERAPEUTICS INC 18.62%ABCL : ABCELLERA BIOLOGICS INC 8.38%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for OCULAR THERAPEUTIX INC is calculated as follows: CashnEq [ $ 72.41M ] / Assets [ $ 98.22M ]
(=) Cash to Assets [ 73.72% ]

OCUL - Cash to Assets Ratio, Last 5 years

55.79%

Minimum

Jun 30, 2023

89.93%

Maximum

Mar 31, 2024

79.65%

Average

82.07%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.83% with a standard deviation of 9.6%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.95K
min0%
max40.89%
average9.83%
median6.44%
std9.6%